What is the global market size of Digital Biomarkers Market?

Digital Biomarkers Market size was valued at around USD 2.43 billion in 2021 and is expected to rise from USD 2.96 billion in 2022 to reach a value of USD 14.44 Billion by 2030, at a CAGR of 21.9 % over the forecast period (2022–2030).

Who are the key vendors in the Global Digital Biomarkers Market?

The nature of the global digital biomarkers market is characterized by intense competition and rapid technological advancements. Companies operating in this market are focusing on product innovation, partnerships, collaborations, and mergers and acquisitions to gain a competitive edge. Companies are investing in R&D to develop new and innovative products that offer advanced features and capabilities. 'ActiGraph LLC', 'AliveCor Inc.', 'Koneksa', 'Altoida Inc.', 'Amgen Inc.', 'Biogen Inc.', 'Empatica Inc.', 'Vivo Sense', 'IXICO plc', 'Adherium Limited', 'Neurotrack Technologies, Inc.', 'Aural Analytic', 'Huma', 'Sonde Health, Inc.', 'Clario', 'Imagene AI', 'Brainomix', 'Kinsa Inc.', 'Feel Therapeutics', 'ResApp (Pfizer)'.

What is the key driver of Global Digital Biomarkers Market?

The rising incidence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is driving the demand for digital biomarkers, as they can help in early detection and management of these conditions.

What is the key market trend for Global Digital Biomarkers Market?

Wearables and mobile health apps: Wearables and mobile health apps are becoming increasingly popular among consumers and healthcare providers, as they enable continuous and remote monitoring of patients. This trend is driving the growth of the digital biomarkers market, as these devices generate a large amount of data that can be used to develop digital biomarkers.

Which region accounted for the largest share in Global Digital Biomarkers Market?

North America dominated the market and held a revenue share of over 59.0% in 2022, which can be attributed to the region's enhanced awareness of the efficacy of digital biomarkers as well as the region's substantial number of key market players, significant product launches, increase in investment in research and development, and growing acceptance of smart devices. A few other key factors for this area to forecast market expansion include the increasing number of initiatives to improve healthcare IT and the existence of healthcare programmers. Additionally, it is anticipated that the market in North America will be driven by the strategic initiatives of the region's market participants and significant R&D expenditure.

Digital Biomarkers Companies

Digital Biomarkers Market Competitive Landscape

Digital Biomarkers Market Top Player’s Company Profiles

ActiGraph LLC (US)
AliveCor Inc. (US)
Koneksa (US)
Altoida Inc. (US)
Amgen Inc. (US)
Biogen Inc. (US)
Empatica Inc. (US)
IXICO plc (UK)
Adherium Limited (New Zealand)
Neurotrack Technologies, Inc. (US)
Aural Analytics (US)
Huma (UK)
Sonde Health, Inc. (US)
Clario (US)
Imagene AI (Israel)
Brainomix (UK)
Kinsa Inc. (US)
Solve.Care (Estonia)
HIVE Blockchain Technologies Ltd. (Canada)
Encrypgen (US)
Sana Benefits (US)
Healthereum (US)
Patientory (US)

Digital Biomarkers Market

FAQs

Digital Biomarkers Market size was valued at USD 2.96 Billion in 2023 and is poised to grow from USD 3.61 Billion in 2024 to USD 17.6 Billion by 2032, growing at a CAGR of 21.9% during the forecast period (2025-2032).

The global digital biomarkers market outlook is characterized by rapid technical breakthroughs, intense rivalry, and new investment. Companies in this sector are directing their attention to partnerships, collaborations, innovative products, and mergers and acquisitions to obtain a competitive advantage. Companies are investing in R&D to produce new, advanced products with the most modern features and capabilities. 'ActiGraph LLC (US) ', 'AliveCor Inc. (US) ', 'Koneksa (US) ', 'Altoida Inc. (US) ', 'Amgen Inc. (US) ', 'Biogen Inc. (US) ', 'Empatica Inc. (US) ', 'IXICO plc (UK) ', 'Adherium Limited (New Zealand) ', 'Neurotrack Technologies, Inc. (US) ', 'Aural Analytics (US) ', 'Huma (UK) ', 'Sonde Health, Inc. (US) ', 'Clario (US) ', 'Imagene AI (Israel) ', 'Brainomix (UK) ', 'Kinsa Inc. (US) ', 'Solve.Care (Estonia) ', 'HIVE Blockchain Technologies Ltd. (Canada) ', 'Encrypgen (US) ', 'Sana Benefits (US) ', 'Healthereum (US) ', 'Patientory (US) '

The incidence of diabetes, hypertension, and cardiovascular conditions continues to escalate and underlines the growing demand for digital biomarkers. Digital biomarkers offer crucial information that ensures immediate reaction and uninterrupted monitoring by healthcare systems towards chronic illnesses. It encourages best management practices that allow patients to stay healthy for longer periods and to be hospitalized fewer times, thus contributing toward improved quality of life while reducing healthcare expenditure.

Integration of AI: One of the major digital biomarkers market trends is the integration of AI. It may be that all wearables and health application-generated data could end up processed by AI algorithms and result in patterns and insights that doctors might not immediately identify. That said, however, this trend enables more proactive and individualized approaches to healthcare, better management of an illness, and better results by improving the predictive power of the digital biomarkers.

North America secured the highest digital biomarkers market share in 2023 at 58.4% compared to other markets, leading to increased R&D spending, the presence of major market players, growing acceptance of smart devices, major product launches, and the growing knowledge of the efficacy of digital biomarkers in that region. The market is also expanding due to the growing number of programs encouraging healthcare infrastructure construction. The Digital Biomarker Summit USA, organized in Tarrytown, New York, by the Digital Biomarkers Summit USA event in May 2024, featured and presented key notes and a discussion on the topic: digital biomarkers in clinical trials, bringing instances with wearable technology that provide aspects of AI integration. In addition, digital phenotyping and how this affects observational research was investigated. It has also focused on new innovations and improvements in regulatory preparedness to embrace these cutting-edge endpoint measurement techniques. These are expected to sustain a high requirement of uptake and breadth of digital biomarker in the region.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Digital Biomarkers Market Competitive Landscape

Digital Biomarkers Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Digital Biomarkers Market Competitive Landscape

Digital Biomarkers Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Digital Biomarkers Market?

Who are the key vendors in the Digital Biomarkers Market?

What is the key driver of Digital Biomarkers Market?

What is the key market trend for Digital Biomarkers Market?

Which region accounted for the largest share in Digital Biomarkers Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300